Insider Plans Sale of 29,950 Celestica Shares

Celestica Inc. insider Leila Wong has filed to sell 29,950 common shares under Rule 144.

Rhea-AI Filing Summary

Celestica Inc. insider Leila Wong has filed to sell 29,950 common shares under Rule 144. The planned sale is to be executed through Canaccord Genuity on the NYSE, with an aggregate market value of 8,415,650.5. Celestica had 115,036,621 common shares outstanding.

The shares to be sold were acquired on 02/02/2026 through the vesting of 28,450 performance share units and 1,500 restricted share units, both from Celestica Inc. In the past three months, Wong sold 3,160 common shares on 12/01/2025 for gross proceeds of 1,021,880.8.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Celestica (CLS) Form 144 filing disclose?

The filing discloses that insider Leila Wong plans to sell 29,950 Celestica common shares under Rule 144. The sale will be executed through Canaccord Genuity on the NYSE, based on an aggregate market value of 8,415,650.5.

How many Celestica (CLS) shares is the insider planning to sell?

The insider plans to sell 29,950 common shares of Celestica Inc. These shares were recently acquired through vesting of 28,450 performance share units and 1,500 restricted share units, all dated 02/02/2026, and are being registered for sale under Rule 144.

How were the Celestica (CLS) shares in the Form 144 acquired?

The shares were acquired on 02/02/2026 through equity compensation. Specifically, 28,450 shares came from performance share unit vesting and 1,500 shares from restricted share unit vesting, both granted by Celestica Inc. and settled on that same date.

What recent Celestica (CLS) share sales has the insider made?

During the past three months, Leila Wong sold 3,160 Celestica common shares on 12/01/2025, generating 1,021,880.8 in gross proceeds. This prior transaction is reported alongside the new planned sale of 29,950 shares in the current Form 144 notice.

How many Celestica (CLS) shares are outstanding in this Form 144?

The filing reports that 115,036,621 Celestica common shares were outstanding. This figure provides context for the planned sale of 29,950 shares by insider Leila Wong under Rule 144 through Canaccord Genuity on the NYSE.

Which broker and exchange are used for the Celestica (CLS) Rule 144 sale?

The planned Rule 144 sale will be carried out through Canaccord Genuity, located at 40 Temperance Street, Suite 2100, Toronto. The 29,950 common shares of Celestica Inc. are expected to be sold on the NYSE, as stated in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973208
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CELESTICA INC.
SEC File Number	001-14832
Address of Issuer	5140 Yonge Street, Suite 1900 Toronto ONTARIO, CANADA M2N 6L7
Phone	416-448-5800
Name of Person for Whose Account the Securities are To Be Sold	Wong Leila
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Canaccord Genuity 40 Temperance Street Suite 2100 Toronto A6 M5H 0B4	29950	8415650.5	115036621	02/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	02/02/2026	Performance share unit vesting	Celestica Inc.			28450	02/02/2026	N/A
Common Shares	02/02/2026	Restricted share unit vesting	Celestica Inc.			1500	02/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leila Wong 5140 Yonge Street Suite 1900 Toronto A6 M2N 6L7	Common Shares	12/01/2025	3160	1021880.8

144: Remarks and Signature

Remarks	The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the Issuer.
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Leila Wong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)